The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERATED DIAGNOSTICS INC | COM | 00430H102 | 1,612 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| ACHAOGEN INC | COM | OO4449104 | 718 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 5,380 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| AFFIMED N V | COM | N01045108 | 4,236 | 595,000 | SH | SOLE | 595,000 | 0 | 0 | ||
| AGILE THERAPEUTICS INC | COM | 00847L100 | 2,928 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 2,147 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 4,529 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 3,326 | 1,760,000 | SH | SOLE | 1,760,000 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 8,188 | 1,310,000 | SH | SOLE | 1,310,000 | 0 | 0 | ||
| AURIS MED HLDG AG | COM | H03579101 | 1,834 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
| AVINGER INC | COM | 053734109 | 4,315 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 10,600 | 2,120,000 | SH | SOLE | 2,120,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 325 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 7,244 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 7,199 | 427,000 | SH | SOLE | 427,000 | 0 | 0 | ||
| CELLECTIS S A | SPONSORED ADS | 15117K103 | 1,552 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 6,226 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 6,768 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
| CORIUM INTL INC | COM | 21887L107 | 2,883 | 355,000 | SH | SOLE | 355,000 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 1,682 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| CYTRX CORP | COM PAR $.001 | 838828509 | 3,816 | 1,440,000 | SH | SOLE | 1,440,000 | 0 | 0 | ||
| DEPOMED INC | COM | 249908104 | 5,439 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| EAGLE PHARMACEUTICALS INC | COM | 269796108 | 7,537 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| EVOKE PHARMA INC | COM | 30049G104 | 429 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 9,903 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| FLAMEL TECHNOLOGIES SA | SPONSORED ADR | 338488109 | 3,053 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 4,055 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 8,833 | 1,825,000 | SH | SOLE | 1,825,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 890 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
| IMPRIMIS PHARMACEUTICALS INC | COM NEW | 45323A201 | 8,351 | 1,205,000 | SH | SOLE | 1,205,000 | 0 | 0 | ||
| INOTEK PHARMACEUTICALS CORP | COM | 45780VAA0 | 7,308 | 645,000 | SH | SOLE | 645,000 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 3,377 | 630,000 | SH | SOLE | 630,000 | 0 | 0 | ||
| LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459904 | 3,780 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 1,084 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| MEDGENICS INC | COM NEW | 58436Q203 | 8,368 | 1,390,000 | SH | SOLE | 1,390,000 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 2,116 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 3,111 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 8,246 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365AAB7 | 8,262 | 8,100,000 | SH | SOLE | 8,100,000 | 0 | 0 | ||
| RELYPSA INC | COM | 759531106 | 6,235 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 6,655 | 345,000 | SH | SOLE | 345,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 5,830 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| SANGAMO BIOSCIENCES INC | COM | 800677106 | 548 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 5,645 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM | 88032L100 | 1,771 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 3,579 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260201 | 4,334 | 565,000 | SH | SOLE | 565,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 2,648 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 12,340 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| VITAE PHARMACEUTICALS INC | COM | 92847N103 | 1,059 | 58,500 | SH | SOLE | 58,500 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,412 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| XOMA CORP DEL | COM | 98419J107 | 2,261 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L105 | 2,211 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||